The DOI matches its Crossref record; 58 of the 61 references it cites were found in a registry or an index.
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function
Open accessAbstract
BRCA1 interacts in vivo with a novel protein, BACH1, a member of the DEAH helicase family. BACH1 binds directly to the BRCT repeats of BRCA1. A BACH1 derivative, bearing a mutation in a residue that was essential for catalytic function in other helicases, interfered with normal double-strand break repair in a manner that was dependent on its BRCA1 binding function. Thus, BACH1/BRCA1 complex formation contributes to a key BRCA1 activity. In addition, germline BACH1 mutations affecting the helicase domain were detected in two early-onset breast cancer patients and not in 200 matched controls. Thus, it is conceivable that, like BRCA1, BACH1 is a target of germline cancer-inducing mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The purified 130-kDa protein was subject to tandem mass spectrometry and the FANCJ gene was cloned and found to consist of 20 exons spanning greater than 180 kb of genomic sequence in chromosome 17q22.”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Furthermore, unlike the classic paradigm for tumor suppressor genes, in which the tumor exclusively lacks the wild-type allele, tumors of individuals who were heterozygous for these two germline FANCJ mutations did not show loss of the corresponding wild-type allele [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“For example, the P47A variant identified in 2001 [8] and shown to disrupt FANCJ enzyme function [56] was found in the controls of a subsequent study and considered to be unrelated to breast cancer [44].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Among the proteins identified was a protein of approximately 130 kDa that failed to interact with a BRCA1, harboring patient mutations within the BRCT motifs (P1749R and M1775R) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Most notably, the protein product had strong homology to the catalytic and nucleotide-binding domains of other members within the DEAH helicase family, including the xeroderma pigmentosum complimenting group D (XPD) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In keeping with this suggestion, two patients with a family history and early-onset breast cancer were identified that had discrete germline sequence changes, P47A and M299I, targeting the helicase domain of FANCJ [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Moreover, the aforementioned P47A mutant had a reduced protein half-life when overexpressed in tissue culture cells [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In particular, overexpression of the helicase-inactive K52R mutant in cells with wild-type FANCJ resulted in the accumulation of unrepaired DNA breaks when analyzed by pulse field electrophoresis [8], as well as reduced homologous recombination following double strand break induction [69].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“BRCA1 clinical mutations target the BRCT region required for FANCJ binding [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045
Self-citationDynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Self-citation
Research works printed but not linked: 1
- Ma, 1994, Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation, Mol. Cell. Biol., 14, 4126, 10.1128/MCB.14.6.4126 · DOI
Cited by
Sorted by citations
Items 501–600 of 676
Takashima, K., Nakajima, K., Shimizu, S., Ojiro, R., Tang, Q., Okano, H., Takahashi, Y., Ozawa, S., Jin, M., Yoshinari, T., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.06.006 · Cited by 8
BRCA1 and BRCA2 in Breast Cancer Predisposition and Recombination Control
Scully, R., & Xie, A. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048771.93906.3e · Cited by 8
Improving information retrieval in functional analysis
Rodríguez, J. C., González, G. A., Fresno, C., Llera, A. S., & Fernández, E. A. (2016) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2016.09.017 · Cited by 8
Dai, J., Li, Z., Amos, C. I., Hung, R. J., Tardón, A., Andrew, A. S., Chen, C., Christiani, D. C., Albanes, D., van der Heijden, E. H. F. M., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy187 · Cited by 8
Kraemer, D., Azzarello‐Burri, S., Steindl, K., Boonsawat, P., Zweier, M., Dedes, K. J., Joset, P., Fink, D. A., & Rauch, A. M. (2019) · Swiss Medical Weekly · doi:10.4414/smw.2019.20092 · Cited by 9
Disruption of the fanconi anemia pathway in human cancer in the general population
Jacquemont, C. F., & Taniguchi, T. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3658 · Cited by 8
Kamal, L., Pierce, S. B., Canavati, C., Rayyan, A. A., Jarayseh, T., Lobel, O., Lolas, S., Norquist, B. M., Rabie, G., Zahdeh, F., et al. (2020) · Molecular Case Studies · doi:10.1101/mcs.a005652 · Cited by 8
Long, G., Hu, K., Zhang, X., Zhou, L., & Li, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-31109-6 · Cited by 7
Li, Y., Maimaiti, M., Yang, B., Lu, Z., Zheng, Q., Lin, Y., Luo, W., Wang, R., Ding, L., Wang, H., et al. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110888 · Cited by 7
Bach1 Deficiency Ameliorates Radiation Pneumonitis via Activating TFAM Signaling Pathway
Huang, J., Zhang, Y. L., Jiang, F., Zhang, Y., He, S., He, S., Sun, J., Chen, D., Pang, Q., & Wu, Y. (2025) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0742 · Cited by 8
Flaum, N., van Veen, E. M., Smith, O., Amico, S., Newman, W. G., Crosbie, E. J., Edmondson, R. J., Smith, M. J., & Evans, D. G. (2021) · Clinical Genetics · doi:10.1111/cge.14068 · Cited by 7
BCLAF1, a functional partner of BACH1, participates in DNA damage response
Jiang, K., Ding, Y., Dong, C., Shan, F., Guo, K., Zhang, J., & Zhang, F. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103371 · Cited by 7
G4-interacting proteins endangering genomic stability at G4 DNA-forming sites
Kim, N. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221018 · Cited by 7
Becker, R. A., & Hub, J. S. (2023) · Communications Biology · doi:10.1038/s42003-023-04751-z · Cited by 7
BRIP1/FANCJMutation Analysis in a Family with History of Male and Female Breast Cancer in India
Ananthapur, V., Clark, D. W., Nallari, P., Cingeetham, V., Kumarasamy Thangaraj, K., Reddy, G., Jyothy, A., Kumar, M. V., Ramaiyer, R., & Palle, K. (2017) · Journal of Breast Cancer · doi:10.4048/jbc.2017.20.1.104 · Cited by 7
Genetic instability in the RAD51 and BRCA1 regions in breast cancer
Nowacka‐Zawisza, M., Bryś, M., Romanowicz‐Makowska, H., Kulig, A., & Krajewska, W. M. (2006) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-006-0063-x · Cited by 7
Shi, J. C., Tong, J., Cai, S., Qu, X., & Liu, Y. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1148 · Cited by 7
ADN hélicases et maladies associées
Uhring, M., & Poterszman, A. (2006) · médecine/sciences · doi:10.1051/medsci/200622121087 · Cited by 8
No mutations in the XRCC2 gene in BRCA1/2‐negative high‐risk breast cancer families
Rodríguez‐López, R., Osório, A., Sánchez‐Pulido, L., de la Hoya, M., Barroso, A., Caldés, T., & Benitez, J. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10766 · Cited by 8
BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer
Sólyom, S. (2011) · Cited by 7
Iron–Sulfur Clusters: Assembly and Biological Roles
Maio, N. (2024) · Inorganics · doi:10.3390/inorganics12080216 · Cited by 8
Haanpää, M. K. (2014) · Cited by 6
Sakasai, R., Sakai, A., Iimori, M., Kiyonari, S., Matsuoka, K., Kakeji, Y., Kitao, H., & Maehara, Y. (2012) · Genes to Cells · doi:10.1111/gtc.12011 · Cited by 6
Genomic analysis of an aggressive case with metastatic intrahepatic mucinous cholangiocarcinoma
Masaki, Y., Akutsu, N., Adachi, Y., Ishigami, K., Iwata, N., Endo, T., Ishii, Y., Sasaki, Y., Nagayama, M., Kimura, Y., et al. (2022) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-022-01649-x · Cited by 6
Stanley, E. C., Azzinaro, P. A., Vierra, D. A., Howlett, N. G., & Irvine, S. Q. (2016) · Evolutionary Bioinformatics · doi:10.4137/ebo.s37920 · Cited by 6
Liu, D., Zheng, Y., Wang, M., Deng, Y., Lin, S., Zhou, L., Yang, P., Dai, C., Xu, P., Hao, Q., et al. (2018) · Aging · doi:10.18632/aging.101388 · Cited by 7
Client recruitment mechanism of the cytosolic Fe-S cluster assembly targeting complex
Ren, W., Huang, Y., Hu, M., Yang, Y., Yang, W., & Wang, H. (2026) · The EMBO Journal · doi:10.1038/s44318-025-00676-x · Cited by 5
Diouf, O. B., Gilbert, A., Bernay, B., Syljuåsen, R. G., Tudor, M., Temelie, M., Savu, D., Soumboundou, M., Sall, C., & Chevalier, F. (2024) · Proteomes · doi:10.3390/proteomes13010001 · Cited by 5
Kurdekar, V., Giridharan, S., Jasti, S., Nijaguna, M. B., Periasamy, J., Boggaram, S. S., Shivange, A. V., Sadasivam, G., Padigaru, M., Potluri, V. K., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900300 · Cited by 5
Chen, Z., & Chen, J. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000356 · Cited by 5
BARD1 is an ATPase activating protein for OLA1
Chen, T., Yeh, H., Chen, P.-P., Huang, W.-T., Wu, C.-Y., Liao, T.-C., Lin, S.-L., Chen, Y.-Y., Lin, K., Hsu, S. D., et al. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130099 · Cited by 5
Natural Ionizing Radiation and Health
Bølviken, B. (2002) · Cited by 5
Rose, A. M. (2014) · WormBook · doi:10.1895/wormbook.1.54.2 · Cited by 5
ATM , ATR and Mre11 complex genes in hereditary susceptibility to breast cancer
Pylkäs, K. (2007) · Cited by 5
Regulated Expression of a FANCL Splicing Variant as a Potential Modifier of DNA Repair Activity
(2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000143 · Cited by 4
Tanaka, K., Suzuki, K., Miyashita, K., Wakasa, K., Kawano, M., Nakatsu, Y., Tsumura, H., Yoshida, M. A., & Oda, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-19164-x · Cited by 4
A Parallelizable Framework for Segmenting Piecewise Signals
Duan, J., Soussen, C., Brie, D., Idier, J., Wang, Y.-P., & Wan, M. (2018) · IEEE Access · doi:10.1109/access.2018.2890077 · Cited by 4
Positional analyses of BRCA1-dependent expression in Saccharomyces cerevisiae
Skibbens, R. V., Ringhoff, D. N., Marzillier, J. Y., Cassimeris, L., & Eastman, L. (2008) · Cell Cycle · doi:10.4161/cc.7.24.7380 · Cited by 4
Caenorhabditis elegans as a model for biomarkers of diseases and toxicities
Fitsanakis, V. A., Negga, R., & Hatfield, H. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00006-3 · Cited by 4
Hereditary Breast and Ovarian Cancer Genes
Scully, R., & Puget, N. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:041 · Cited by 4
Bases génétiques de la radiosensibilité des cancers du sein
Delaloge, S., & Marsiglia, H. R. (2005) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2004.11.003 · Cited by 4
Biochemical and Cellular Aspects of Homologous Recombination
van Veelen, L. R., Wesoły, J., & Kanaar, R. (2005) · CRC Press eBooks · doi:10.1201/9780849352683.pt6 · Cited by 4
Woo, I. M. H., Casadei, S., Snyder, M. W., Smith, N. T., Best, S., Tejura, M., Gupta, P., McEwen, A. E., Post, M., Hamm, A., et al. (2025) · medRxiv · doi:10.1101/2025.11.03.25339440 · Cited by 5
Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution
Mangkusaputra, V., Murachelli, A. G., Yu, Z., den Hollander, A., Menafra, R., Schreuder, A., Kloet, S. L., Sixma, T. K., & Noordermeer, S. M. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf848 · Cited by 7
Rare genetic diseases associated with G-quadruplex-induced replication stress
Herr, L. M., Mukhopadhyay, S., Anderson, O. M., Couch, T. H., Jones, C. M., Brosh, R. M., & Rossi, M. S. (2026) · Communications Biology · doi:10.1038/s42003-026-09966-4 · Cited by 4
BRCA1 frameshift variants leading to extended incorrect protein C termini
Nepomuceno, T. C., Foo, T. K., Richardson, M. E., Rañola, J. M. O., Weyandt, J. D., Varga, M. J., Alarcon, A., Gutierrez, D., von Wachenfeldt, A., Eriksson, D., et al. (2023) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2023.100240 · Cited by 3
Qu, H., Delfiner, M. S., Gangireddy, C., Vaidya, A., Nguyen, K., Whitman, I. R., Wang, J., Song, J., Bristow, M. R., McTiernan, C. F., et al. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02510-z · Cited by 3
Jinks-Robertson, S. (2002) · Nature Genetics · doi:10.1038/ng936 · Cited by 3
Insight into the DNA repair mechanism operating during cell cycle checkpoints in eukaryotic cells
Asimuddin, M., & Jamil, K. (2012) · Biology and medicine · doi:10.4172/0974-8369.1000173 · Cited by 3
Katheeja Muhseena, N., Das, S. P., & Laha, S. (2021) · Cell Division · doi:10.1186/s13008-021-00072-x · Cited by 3
Kurdekar, V., Giridharan, S., Jasti, S., Nijaguna, M. B., Periasamy, J., Boggaram, S. S., Bharatham, K., Potluri, V. K., Shivange, A. V., Sadasivam, G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/555623 · Cited by 2
Jimenez, D. A., Walker, A. K., Usdin, K., & Zhao, X.-N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062655 · Cited by 2
Mitotic single-stranded DNA suppression by DDIAS
Xue, Y., Rashed, F. B., Mao, D. Y. L., Abe, K. T., Lin, Z., Krastev, D. B., Setiaputra, D., Hoeg, L., Bonnet, C., Kumar, A., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.07.034 · Cited by 3
Bacillus subtilis DinG 3′⟶5′ Exo(ribo)nuclease: A Helpmate to Mitigate Replication Stress
Carrasco, B., Torres, R., López-Sanz, M., Hernández-Tamayo, R., Graumann, P. L., & Alonso, J. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199681 · Cited by 2
BLM and FANCJ role in the response to G-quadruplex-dependent telomeric replicative stress
Bonanni, L., Muoio, D., Fouquerel, E., Perelli, A., Salvati, E., Berardinelli, F., & Antoccia, A. (2026) · Communications Biology · doi:10.1038/s42003-025-09367-z · Cited by 3
Heer, C. D., Elia, J. L., Menon, V., Johnson, S. S., Arbelaez, S. R., Friedman, S., Lopez-Giraldez, F., Sundaram, R. K., Herzon, S. B., Bindra, R. S., et al. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf052 · Cited by 3
Long, Q., Yuan, Y., Liu, Z., Zhang, P., & Yuan, X. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2026.159734 · Cited by 2
Germline pathogenic variants associated with ovarian cancer: A historical overview
Johansen, E. L., Thusgaard, C. F., Thomassen, M., Boonen, S. E., & Jochumsen, K. M. (2022) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2022.101105 · Cited by 2
Thooft, A. D. J., Joris, S., Jacobs, C., Creytens, D., Rottey, S., Maes, B., Aftimos, P. G., & Lapeire, L. (2025) · Acta Oncologica · doi:10.2340/1651-226x.2025.43374 · Cited by 2
Genetic diagnosis of Fanconi anemia. Literature review
Панферова, А. В., Timofeeva, N. M., & Olshanskaya, Y. V. (2016) · Oncohematology · doi:10.17650/1818-8346-2016-11-3-76-85 · Cited by 2
Fanconi Anemia: A Pathway of Hematopoiesis and Cancer Predisposition
Suliman, A. Y., Smith, F. O., & Kupfer, G. M. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_4 · Cited by 2
Papež, J., Štarha, J., Zerhau, P., Pavlovská, D., Ježová, M., Jurencak, T., Slabá, K., Sterba, M., Kerekes, A., Merta, T., et al. (2021) · Genes · doi:10.3390/genes12020220 · Cited by 2
Wu, X., Chen, Z., Ren, P., Zhao, X., Tang, D., Geng, H., Xu, X., & Zhao, W. (2021) · BioMed Research International · doi:10.1155/2021/5579543 · Cited by 2
Becker, R. A., & Hub, J. S. (2023) · Biological Chemistry · doi:10.1515/hsz-2023-0154 · Cited by 2
The Fanconi Anemia Pathway and Interstrand Cross-Link Repair
Ishiai, M., Tomida, J., Itaya, A., Hejna, J., & Takata, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55873-6_8 · Cited by 2
Genetic and Genomic Factors in Breast Cancer
SHULMAN, L. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5891-3_2 · Cited by 2
Fanconi Anemia Genes: Structure, Mutations, and Genotype-Phenotype Correlations
Kalb, R., Neveling, K., Herterich, S., & Schindler, D. (2007) · KARGER eBooks · doi:10.1159/000102547 · Cited by 2
Singh, S. S., Berroyer, A., Kim, M., & Kim, N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/802876 · Cited by 2
Milano, L., Alenezi, W. M., Fierheller, C. T., Serruya, C., Revil, T., Oros, K. K., Bruce, J. P., Spiegelman, D., Pugh, T. J., Mes‐Masson, A., et al. (2023) · medRxiv · doi:10.1101/2023.07.03.23290133 · Cited by 2
Ohta, T., & Wu, W. (2021) · Springer eBooks · doi:10.1007/978-981-16-4521-1_2 · Cited by 1
Oligonol enhances brain cognitive function in high-fat diet-fed mice
Choi, S. Y., Ahn, S. Y., Jo, D., Kim, O. Y., & Song, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117322 · Cited by 1
Hilgert, E., Neste, C. V., Bekaert, S.-L., Martens, F., Vanhauwaert, S., Sanders, E., Verstraelen, P., Risseeuw, M., Westerhout, E. M., Grannetia, M. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-29898-z · Cited by 1
Milano, L., Alenezi, W. M., Fierheller, C. T., Serruya, C., Revil, T., Oros, K. K., Bruce, J. J., Spiegelman, D., Pugh, T. J., Mes‐Masson, A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021037 · Cited by 3
Regulation of BACH1/FANCJ Function in DNA Damage Repair: A Dissertation
Xie, J. (2009) · eScholarship@UMassChan · doi:10.13028/95cm-wn54 · Cited by 1
DNA damage response genes and chromosome 11q21-q24 candidate tumor suppressor genes in breast cancer
Allinen, M. (2002) · Cited by 1
Next-Generation Sequencing Based Testing for Breast Cancer
Ganesan, S., & Hirshfield, K. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-41761-5_20 · Cited by 1
Self-citationMa, B., Wu, J., & Ma, B. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.1080/13102818.2019.1657039 · Cited by 1
Purification and biochemical characterization of the G4 resolvase and DNA helicase FANCJ
Kulikowicz, T., Sommers, J. A., Fuchs, K. F., Wu, Y., & Brosh, R. M. (2024) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2023.12.006 · Cited by 1
Variant of uncertain significance Arg866Cys enhances disorderedness of h-BRCA1 (759-1064) region
Mishra, N., Dubey, S., Kumari, A., Siddiqui, M. Q., Kuligina, E. S., & Varma, A. K. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106527 · Cited by 1
Han, F.-Y., Wu, R., Miao, B., Niu, S., Wang, Q., & Liang, Z. (2024) · Animals · doi:10.3390/ani14030434 · Cited by 1
Matveevsky, S. N., & Bogdanov, Y. F. (2025) · Cytogenetic and Genome Research · doi:10.1159/000545191 · Cited by 1
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2009) · Springer eBooks · doi:10.1007/978-3-540-79725-8_4 · Cited by 2
Wagner, A. F., SHULMAN, L. P., & Dungan, J. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-02868-8_3 · Cited by 1
Kohzaki, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.934042 · Cited by 1
Palmero, E. I. (2007) · Americanae (AECID Library) · Cited by 1
ATM, RAD50 and p53 in breast cancer
Tommiska, J. (2008) · Työväentutkimus Vuosikirja · Cited by 1
Fanconi Anemia: A Multi-Age Cancer Susceptibility Syndrome
Harney, J. A., Shimamura, A., & Howlett, N. G. (2008) · Pediatric Health · doi:10.2217/17455111.2.2.175 · Cited by 1
Genetic Predisposition to Male and Female Breast Cancer
Syrjäkoski, K. (2004) · Tampere University Institutional Repository (Tampere University) · Cited by 1
BRCA1 et BRCA2 : des échafaudages de réparation des lésions de l'ADN ?
Feunteun, J. (2001) · médecine/sciences · doi:10.4267/10608/1824 · Cited by 1
Regulation of DNA damage response by trimeric G-protein SignalingPreprint
El‐Hafeez, A. A. A., Sun, N. N., Chakraborty, A., Ear, J., Roy, S., Chamarthi, P., Rajapakse, N., Das, S., Luker, K. E., Hazra, T. K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.21.452842 · Cited by 1
Laha, S., Katheeja Muhseena, N., Das, S. P., & Das, R. (2021) · Research Square · doi:10.21203/rs.3.rs-1084603/v1 · Cited by 1
The Fanconi anemia-BRCA Pathway and Cancer
Taniguchi, T. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_17
Kevin, M. J. (2011) · InTech eBooks · doi:10.5772/19486
Characterization of the BACH1 Helicase in the DNA Damage Response Pathway: a Dissertation
Flynn, R. L. (2007) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/ad72-xg56
A Proteomic Approach to Identify Phosphorylation-Dependent Targets of BRCT Domains
Songyang, Z. (2006) · Defense Technical Information Center (DTIC) · doi:10.21236/ada458980
Xenopus laevis as a model system for evaluating the function of fanconi anemia proteins
Stone, S. (2008) · Pure Amsterdam UMC
Investigation of the genetic basis of familial non- BRCA1/2 breast cancer
Maguire, P. T. (2005) · Figshare
Metadata
- Authors
- Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Livingston, David M.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 105
- Issue
- 1
- Pages
- 149-160
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2109173575
- Cited by
- 674
- References
- 61
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 20 · 2023: 25 · 2022: 17 · 2021: 32 · 2020: 23 · 2019: 27 · 2018: 14 · 2017: 20 · 2016: 33 · 2015: 29 · 2014: 24 · 2013: 21 · 2012: 35
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007627, T32-HL07627-16)
- National Cancer Institute (P50 CA 89393, P50CA089393)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BACH1, BRCA1, protein-protein interaction, DNA double-strand break repair, homologous recombination, germline mutations, early-onset breast cancer, cancer susceptibility genes
- MeSH terms
- Adult, Binding Sites, Boston, Breast Neoplasms, Cell Line, Chromosomes, Human, Pair 17, DNA Repair, DNA Helicases, DNA-Binding Proteins, Female, Genetic Testing, Humans, Molecular Sequence Data, Protein Binding, Recombinant Fusion Proteins, Transfection, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Protein Structure, Tertiary, BRCA1 Protein, Genetic Predisposition to Disease, RNA Helicases, Amino Acid Motifs, Spectrometry, Mass, Electrospray Ionization, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
